News Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Staff September 11, 2023 Post Views: 34 Related Continue Reading Previous New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral ClearanceNext XORTX Announces Participation at Upcoming Investor Conferences More Stories Healthcare News NuGen Medical Completes Delivery and First Sale of 500 InsuJet(TM) Devices and Consumables in Romania Staff September 20, 2023 News Izotropic Closes Non-Brokered Private Placement Staff September 20, 2023 News Yada Yoga Extends Wellness Support to Protestors in the Entertainment Industry on the Picket Lines Staff September 20, 2023
